BRAF and rheumatoid arthritis: According to the results of molecular docking, in the context of rheumatoid arthritis, phytocannabinoids may bind to important target proteins such as PIK3CA, AKT1, MAPK9, PRKCD, BRAF, IGF1R, and NOS3.